Study to Evaluate Rate of Nausea in Healthy Premenopausal Female Subjects Treated With Single Dose of Bremelanotide Alone or With Zofran
NCT03973047
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
228
Enrollment
INDUSTRY
Sponsor class
Conditions
Nausea
Interventions
DRUG:
Bremelanotide
DRUG:
Zofran
DRUG:
Placebo
Sponsor
AMAG Pharmaceuticals, Inc.